More insights on the dysglycaemia-cardiovascular connection

The Lancet

Volumn 375, Issue 9733, 2010, Pages 2195-2196

  Gerstein, Hertzel C ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSGLYCAEMIA; FATTY ACID METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HEART INFARCTION; HUMAN; LIPID STORAGE; LIPOPROTEIN METABOLISM; LIVER FUNCTION; METABOLIC DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 77953868829     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60973-7     Document Type: Note

References (12)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33 suppl 1 (2010) S62-S69
2. Gerstein H.C., Santaguida P., Raina P., et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78 (2007) 305-312
3. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362 (2010) 800-811
4. Sung J., Song Y.M., Ebrahim S., and Lawlor D.A. Fasting blood glucose and the risk of stroke and myocardial infarction. Circulation 119 (2009) 812-819
5. Gerstein H.C. Dysglycemia and cardiovascular risk in the general population. Circulation 119 (2009) 773-775
6. Stocks T., Rapp K., Bjorge T., et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (Me-Can): analysis of six prospective cohorts. PLoS Med 6 (2009) e1000201
7. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010) 2215-2222
8. Huxley R., Barzi F., and Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332 (2006) 73-78
9. Cowie C.C., and Harris M.I. Physical and metabolic characteristics of persons with diabetes. In: Harris M.I., Cowie C.C., Stern M.S., Boyko E.J., Reiber G.E., and Bennett P.H. (Eds). Diabetes in America. 2nd edn. (1995), National Institutes of Health, Bethesda, MD 117-164
10. Turnbull F.M., Abraira C., Anderson R.J., et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52 (2009) 2288-2298
11. The ORIGIN Trial Investigators. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 155 (2008) 26-32
12. Gerstein H.C. Is it possible to reduce cardiovascular risk with glucose-lowering approaches?. Nat Rev Endocrinol 5 (2009) 270-275